Skip to main content
. 2021 May 12;32(6):320–326. doi: 10.5830/CVJA-2020-065

Table 5. ECG abnormalities in the study groups and controls.

HIV+ on HAART HIV+ HAART-naïve
ECG abnormalities Controls X2 p-value
LAD 15 10 8 2.656 0.265
T-wave inversion leads VI-VIII 44 22 14 24.682 < 0.001
Low-voltage complex 1 0 0 2.007 0.367
1st-degree heart block 3 1 2 1.020 0.600
T-wave inversion 4.811 0.090
leads II, III aVF (inferior leads) 2 1 6
VEB 0 1 0 2.007 0.367
T-wave inversion leads I, avL, V5-V6 0 2 2 2.027 0.363
LBBB 1 0 0 2.007 0.367
RBBB 1 0 2 2.020 0.364
LVH 0 8 0 16.438 < 0.001
Tachycardia 0 1 2 2.020 0.364
ST-segment 0 2 0 4.027 0.134
elevation
Bradycardia 0 0 12 25.000 < 0.001
Mean QTc, mean + SD 0.42 + 0.04 0.41 + 0.04 0.39 + 0.03
Prolonged QTc, n (%) 17 (18.2) 12 (16.4) 4 (10.5) 8.784 0.012
Total, n (%) 93 (100) 73 (100) 38 (100)

For QTc, F = 15.779; p < 0.001. Duncan’s post hoc multiple comparisons test showed all significantly different.

LAD: left-axis deviation; VEB: ventricular ectopic beat; LBBB: left bundle branch block; RBBB: right bundle branch block; LVH: left ventricular hypertrophy.